D. Lazovich et al., CHANGE IN THE USE OF BREAST-CONSERVING SURGERY IN WESTERN WASHINGTON AFTER THE 1990 NIH-CONSENSUS-DEVELOPMENT-CONFERENCE, Archives of surgery, 132(4), 1997, pp. 418-423
Objective: To evaluate the use of breast-conserving surgery in western
Washington before and after the National Institutes of Health Consens
us Development Conference (June 18-21, 1990) during which breast-conse
rving surgery was recommended for most women with early invasive breas
t cancer. Design:Survey. Setting: Population-based cancer registry in
the Seattle-Puget Sound (Washington) region. Participants: The survey
included 13 541 women in whom American Joint Committee on Cancer stage
I or II breast cancer was diagnosed between January 1, 1983, and Dece
mber 31, 1993. Main Outcome Measure: Proportion of participants who un
derwent breast-conserving surgery. Results: From April 1985, after res
ults of a US randomized controlled trial showing equivalent survival i
n women undergoing mastectomy or breast-conserving surgery were publis
hed, to the time of the Conference, breast-conserving surgery was perf
ormed on 44.8% of women with stage I and 25.8% with stage II breast ca
ncer. These percentages increased to 54.9% and 35.2%, respectively, du
ring the post-Conference period. While women with stage II breast canc
er were less likely than women with stage I breast cancer to undergo b
reast-conserving surgery before and after the Conference, trends for a
ge and education were attenuated after the Conference. Differences in
the use of breast-conserving surgery observed before the Conference be
tween counties of residence and among hospital types were also reduced
after the Conference. Conclusions: These findings suggest that the Co
nference recommendations had an effect on the adoption of breast-conse
rving surgery, particularly among groups who were previously least lik
ely to undergo such surgery. Despite progress toward the Conference re
commendation that the majority of women with early invasive breast can
cer undergo breast-conserving surgery, the majority of women with stag
e II breast cancer undergo mastectomy.